People are desperately trying to live forever. Here are the biggest anti-aging t...
source link: https://finance.yahoo.com/news/people-desperately-trying-live-forever-090000189.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
People are desperately trying to live forever. Here are the biggest anti-aging trends sweeping the nation.
Silicon Valley billionaires have long been experimenting with ways to extend the human lifespan.
But the quest for longevity has gone mainstream as more people seek ways to reverse the aging process.
Here are some of the top longevity trends right now, according to industry experts.
People are implementing a range of behavioral and lifestyle practices in the hopes of reversing aging. Some of the most popular practices include…
Source: Insider
Cold exposure
There is a growing body of scientific evidence that supports cold exposure as an anti-aging hack.
Whether you take a plunge into a pool of ice cold water, or try cryotherapy — which involves spending a few minutes in a below freezing chamber — cold exposure has benefits that may help slow down the clock.
Dr. Anant Vinjamoori, Chief Medical Officer of Modern Age, a New York-based healthcare company focused on longevity, told Insider that cold exposure produces effective results in the short and long term.
A plunge into an ice cold bath results in "a surge in the production of neurotransmitters such as epinephrine and dopamine" which have immediate rejuvenating and energizing effects, he said.
"Over the medium to long term, there is some evidence that cold exposure may reduce systemic inflammation, which is known to be a driver of many chronic diseases," Vinjamoori added.
Fasting
In 2019, Jack Dorsey said that he only eats one meal a day and fasts all weekend — which might be bordering on an eating disorder, experts say.
However, research does suggests that time-restricted eating patterns can result in health benefits for those with diabetes and obesity or even enhance the body's defenses against oxidative stress.
"For me, the primary benefit of time-restricted eating is regulating circadian rhythms. Sleep quality almost always improves by limiting the consumption of calories in the evening hours," said Modern Age's Dr. Vinjamoori.
Red light therapy
FortuneDepression too often gets deemed ‘hard to treat’ when medication falls short. An overreliance on it can cause harm
Nearly 3 in 4 who take antidepressants do not get complete relief and are usually categorized as having a difficult-to-treat type of depression referred to, controversially, as “treatment-resistant depression.” We see patients who feel demoralized by the implied and untrue notion that their depression is “incurable."
2d ago
FortuneWith GPT-4, OpenAI’s chief scientist says the company has ‘a recipe for producing magic’
There's a lot the company isn't saying about the powerful new language A.I. model it just released
2d ago
BloombergPopulist Fury Grips Congress in Echo of 2008’s Bailout Backlash
(Bloomberg) -- Populists on both sides of the partisan divide in Washington can agree on one thing: They don’t like last weekend’s rescue of Silicon Valley Bank depositors and want to prevent anything like it from happening again.Most Read from BloombergFirst Republic Bank Is Said to Weigh Options Including a SaleCredit Suisse Reels After Top Shareholder Rules Out Raising StakeRyan Reynolds-Backed Mint Is Bought by T-Mobile for $1.35 BillionIn New York City, a $100,000 Salary Feels Like $36,000T
2d ago
MarketWatchSarepta Therapeutics plummets 20% after FDA contradicts company and requires advisory meeting
Sarepta Therapeutics Inc. (SRPT) shares plummeted in the extended session Thursday after the Food and Drug Administration contradicted the biotech company and said it required an advisory committee meeting for its experimental Duchenne muscular dystrophy drug. Shares of Sarepta dropped as much as 20% after hours, following a 2.9% gain in the regular session to close at $149.67. At the beginning of the month, Sarepta said the FDA did not plan on requiring a meeting, and shares soared 23.5% that day. FDA Advisory Committees make recommendations to the FDA on whether to approve or not approve a drug, but the agency is not bound to the committee’s decision.
16h ago
Yahoo FinanceCMS releases 'bombshell' guidance draft of Medicare drug price negotiations
Medicare issues draft guidance for drug price negotiation
23h ago
Investor's Business DailyIs Pfizer Stock A Buy Or A Sell On Its Looming $43 Billion Seagen Takeover?
Is Pfizer stock a buy or a sell after the company announced its $43 billion plan to buy Seagen? Is PFE stock a buy or a sell?
1d ago
Fortune5 foods a longevity expert eats each day to stay biologically 20 years younger than his age
Dr. Mark Hyman, author of “Forever Young,” says certain foods can help slow the aging process.
23h ago
ZacksBiotech Stock Roundup: ACAD's Drug Approval, SGEN to be Acquired by PFE & More
Acadia's (ACAD) pipeline and regulatory updates, and Seagen's (SGEN) acquisition news are the key highlights from the biotech sector during the past week.
23h ago
BenzingaNovartis' Prostate Cancer Therapy Hit By Supply Crunch, Seeks To Ramp Up Production To Ease Supply Issues
https://cdn.benzinga.com/files/images/story/2023/03/16/nvs.png?optimize=medium&dpr=2&auto=webp&crop=1200%2C800 Last week the FDA said Novartis AG's (NYSE: NVS) Pluvicto is short in supply due to manufacturing and delivery issues. Pluvicto is a radiopharmaceutical medication used for prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer. FDA approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) in march last year, the first targeted radioligand therapy fo
23h ago
The Wall Street JournalShortage of Last-Ditch Drug for Advanced Prostate Cancer Worries Doctors
A drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. Novartis said it is prioritizing the supply for patients who have already started the six-course regimen as it manages the shortage.
1d ago
BenzingaJohnson & Johnson's Experimental Dengue Pill Shows Efficacy In Animal Studies
New data published in the journal Nature shows that Johnson & Johnson's (NYSE: JNJ) experimental dengue pill proved effective against all four virus types in mice and prevented infection from two types in monkeys. The first-in-class antiviral, shown to be safe and well tolerated in Phase 1 first-in-human clinical study, is now progressing into Phase 2 clinical studies to prevent and treat dengue. Reuters writes that early animal results add hope for what could become the first antiviral treatmen
2d ago
FortuneDon’t blame capitalism for America’s health care crisis. Fix the misaligned incentives that make patient outcomes irrelevant
Americans' health care is often tied to the workplace. That makes it hard for insurers to invest in a patient's long-term well-being.
1d ago
AP FinanceNurses, paramedics reach pay deal to end England strikes
Unions representing more than a million health care workers in England, including nurses and paramedics — but not doctors — reached a deal Thursday to resolve months of disruptive strikes for higher wages. The announcement came as early-career physicians spent a third day on picket lines and the day after U.K. Treasury chief Jeremy Hunt announced a budget that included no additional money for labor groups that have staged crippling strikes amid a punishing cost-of-living crisis and double-digit inflation. Any strike actions will be halted while rank-and-file members vote on whether to accept an offer of a lump sum payment for the current year and a 5% raise next year.
22h ago
ZacksMasimo (MASI) PVi Achieves Acceptable Fluid Response in Study
Masimo (MASI) PVi helps clinicians reliably predict fluid responsiveness in young neurosurgical patients.
1d ago
MoneyWise‘I would never put my money into a bank stock ever again’: Kevin O’Leary says the US government has ‘nationalized’ the American banking system. Here’s what he likes instead
Is the government doing more harm than good?
3h ago
The Fiscal TimesYellen Trashes GOP Plan to Prioritize Debt Payments
Appearing before the Senate Finance Committee Thursday, Treasury Secretary Janet Yellen said in no uncertain terms that she does not think a Republican proposal for the U.S. to prioritize its debt payments in the event of a default is viable. The U.S. bumped up against the federal debt limit in January, forcing the Treasury to start taking “extraordinary measures” to make its payments. Absent an increase or suspension in the federal debt limit, the Treasury could be unable to meet its obligation
15h ago
MarketWatchU.S. stocks set for wild swings as trillions in option contracts set to expire Friday
U.S. stocks could see increasingly wild swings in the coming days as option contracts tied to trillions of dollars in securities are set to expire on Friday, removing a buffer that some say has helped to keep the S&P 500 index from breaking out of a tight trading range.
2h ago
TipRanksBillionaire David Rubenstein Loaded Up on These 2 Beaten-Down Stocks — Here’s Why They Could Bounce Back
Will Silicon Valley Bank’s collapse influence the policy makers to take a more forgiving stance regarding its interest rate hiking endeavors? Word on the Street is that it is a possibility, but David Rubenstein is not so sure – the billionaire investor thinks the Fed will find the middle ground in its continued efforts to rein in inflation. “I suspect 25 basis points is the split-the-baby decision that’s most likely,” Rubenstein said ahead of the Federal Reserve’s meeting next week. Whether Rube
1d ago
BloombergSchwab Clients Shift From Prime Funds to Government Portfolios
(Bloomberg) -- Charles Schwab Corp. saw $8.8 billion in net outflows from its prime money market funds this week as investors rattled by turmoil at US banks plowed even more money into the brokerage’s other portfolios that favor assets with government backing.Most Read from BloombergSchwab Clients Shift From Prime Funds to Government PortfoliosHow First Republic Bank Received a $30 Billion LifelineFirst Republic Set to Get $30 Billion of Deposits in RescueIn New York City, a $100,000 Salary Feel
12h ago
Zacks5 Cheap Energy Stocks to Buy Now
Forget the oil producers. Look for deals in services and refining.
15h ago
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK